Streetwise Reports' Article Archives — August 2021 back to current month (119)
Results of MAG Silver's 2020 drill program at its Mexico joint venture project Juanicipio are interpreted in a National Bank of Canada report.
Gatling Exploration’s CEO, Jason Billan, answers the big questions about the company’s high-grade gold deposit in Ontario.
With inflation on the rise and gold at $1,700 an ounce, now is a good time to invest in gold, billionaire hedge fund manager John Paulson proclaimed — and Mark Mobius, founder of Mobius Capital Partners, strongly agrees.
"This marks the first regulatory approval of an OmniAb antibody discovery engine-derived antibody since Ligand Pharmaceuticals first acquired the technology in 2016," noted an H.C. Wainwright & Co. report.
AC Immune SA shares set a new 52-week intraday high after the company reported positive cognitive results for tau-targeting monoclonal antibody semorinemab in a clinical study of patients with mild-to-moderate Alzheimer's disease.
Sierra Madre executes on ‘Hub & Spoke’ strategy with its La Tigra acquisition.
Red Cat Holdings is one of only four companies invited to bid on massive U.S. DOD contracts that could significantly lift sales and boost recurring revenues.
Red Metal Resources' geological team is eyeballing a global copper supply crunch.
Noble Capital Markets commented in a research report that junior mining explorer Aurania Resources Ltd. is presently zeroing in on the most immediate high potential targets at The Lost Cities-Cutucu Project. Noble rates Aurania an "Outperform" as the company's exploration program is delivering an abundance of drilling targets for a variety of metals and offers potential for multiple new discoveries across its large concession package.
The progress Can-Fite BioPharma made with these studies is briefly summarized in a Dawson James Securities report.
An H.C. Wainwright & Co. report noted that Carmat's Aeson implant "could save many patients who may die, due to [a] shortage of donor hearts, while waiting for a heart transplant."
Sector expert Michael Ballanger explains why he expects to "see sharp rebounds in the precious metals" sectors in the next five months.
Shares of Poseida Therapeutics traded 10% higher after the company reported that the U.S. Food and Drug Administration granted clearance for its Investigational New Drug Application for P-BCMA-ALLO1, an allogeneic CAR-T candidate for use in treating relapsed/refractory multiple myeloma.
BMO Capital Markets commented in a research report that MAG Silver Corp. remains on-track with the buildout of its advanced material processing plant at its Juanicipio JV project in Zacatecas state, Mexico expected in Q4/21.
The contents of the preliminary economic assessment on Azarga Uranium's Gas Hills asset and uranium prices are discussed in a Fundamental Research Corp. report.
Shares of Bolt Biotherapeutics Inc. traded nearly 10% higher after the company reported it is collaborating with Innovent Biologics to develop three new oncology Boltbody™ ISAC programs.
In part one of a two-part look at investing in junior precious metals equities, Denver-based Crescat Capital CIO, Kevin Smith, discusses his firm’s perspective on the broad market, its success to date in the precious metals space, and how Crescat’s novel "friendly activist" approach with Geologic and Technical Director Dr. Quinton Hennigh is paying off with the small-cap gold and silver names.
In this episode of Streetwise Live! you will learn about a royalty company that has delivered 492% average quarterly revenue growth (Q3-2020 to Q2-2021).
In today’s Bulletin, we follow-up with developments at some of the junior companies that we omitted from our last letter — all positive — and we comment on two popular music legends who have passed away.
Shares of American Lithium Corp. traded 15% higher after the company reported it registered the highest lithium extraction rates to date of 97.4% from its Tonopah Lithium Claims claystones using a sulfuric acid leaching process.
CIBC World Markets Inc. stated in a research report that MAG Silver posted solid results from its 2020 110-hole drill program at its Juanicipio JV Project in Fresnillo, Mexico. CIBC commented that when the new 4,000 tpd Juanicipio mill comes online it will provide a key catalyst towards growing throughput processing capabilities and expanding the resource.
Adrian Day of Adrian Day's Global Analyst discusses Pan American Silver and Fortuna Silver, two companies he believes, despite their rough patches, offer value to investors.
Investors had been waiting nearly two months, but now the big derisking event has been announced — a US$45M funding package to expand, enhance, and optimize First Cobalt's 100%-owned battery materials refinery in northern Ontario. First Cobalt is one of only a small group of battery materials juniors that will generate meaningful cash flow in 2023.
DICK'S Sporting Goods shares traded nearly 14% higher and climbed to a new 52-week high after the largest U.S.-based, full-line sporting goods retailer reported record quarterly sales and earnings in Q2/21 and boosted its dividend and share repurchases.
MAG Silver's Q2/21 production at Juanicipio is reviewed in a ROTH Capital Partners report.
An H.C. Wainwright report noted that "this deal is an opportunity for STRATA Skin Sciences to substantially increase its long-term, recurring revenue base."
A BTIG report noted that Legend Biotech's cilta-cel has the potential "to take significant market share within the relapsed-refractory multiple myeloma market and establish a best-in-class profile."
Palo Alto Networks shares reached a new 52-week high after the company reported that Q4/21 revenues increased 28% YoY. The company expects the trend to continue and is now anticipating that billings in FY/22 will increase by 21-22% to $6.60-6.65 billion.
New results validate Fabled Silver Gold's interpretation of the mineralized system at its Santa Maria project.
Studies suggest that Galmed Pharmaceuticals' Amilo-5MER has "therapeutic potential in a number of inflammatory diseases," according to an H.C. Wainwright & Co. report.
Trillium Therapeutics shares traded 190% higher after the company reported it agreed to be acquired by pharmaceutical giant Pfizer Inc. for $18.50 per share in cash.
A ROTH Capital Partners report noted that Assertio Therapeutics' business model is starting to gain traction.
Copper Explorer Attracts a Tier 1 Investor (08/23/2021)
Maurice Jackson, of Proven and Probable, and Christian Easterday, CEO of Hot Chili Ltd., discuss the announcement of a new strategic partner, Glencore, and the company's evolution from exploration to now development.
Silver X Mining Corp. reported it intersected intervals of 928.13 g/t Ag eq. over 1.38 m and 631.71 g/t Ag eq over 0.92 m while carrying out expansion drilling at its Tangana 1 Project in Peru.
The recently sluggish gold market is now poised for a major upleg, and Clive Maund points to a dramatic reversal candle at key support as a "major Buy sign."
Chris Temple, editor and publisher of The National Investor, explains why he is adding Carbon Streaming Corp. as a "BUY" to his list of growth-oriented companies.
Pretium Resources "accomplished another profitable quarter," ending with $400.8M in-hand.
Recent drill results from two targets at Aurania Resources' Lost Cities–Cutucu project are reviewed in a Noble Capital Markets report.
A Stifel report noted MAG Silver "demands a higher premium given its 'royalty-like' structure and strong, near-term-free cash flow."
Sitka Gold reported that during its 2021 drilling campaign, it intercepted 318m of 0.45 g/t gold in the Saddle Zone along with 354m of 0.41 g/t gold in the Eiger Zone at its RC Gold Project in the Yukon.
Shares of natural cannabis firm Flora Growth Corp. rose 43% after the company reported H1/21 financial results and indicated it expects H2/21 revenues will be in the range of US$9-11 million.
Streetwise Reports speaks to Frontier Lithium CEO Trevor Walker about this 'serious project with huge opportunity and upside.'
Freeport Resources Inc. reported it has completed its previously announced acquisition of Carpo Resources Inc. giving it a controlling interest in the exploration license for the Yandera Copper Project.
Macy's shares traded 20% higher after the company reported Q2/21 financial results and significantly raised its FY/21 sales and earnings guidance, reinstated its regular quarterly dividend, and instituted a $500 million share repurchase program.
Inovalon Holdings Inc. shares traded 8% higher after the cloud healthcare technology platform firm reported it entered into an agreement to be acquired by an equity consortium led by Nordic Capital and Insight Partners for $41.00 per share in cash.
A Raymond James report noted that MAG Silver "is one of the better options for investors looking for exposure to silver."
An H.C. Wainwright & Co. report noted Oncolytics Biotech's overall pelareorep program is on track with several near-term catalysts expected.
The deal validates Red Cat Holdings' strategy of supplying the drone industry with an array of products, services, and solutions.
Royalty Companies Report Record Revenues (08/18/2021)
In Adrian Day's Global Analyst, Adrian Day writes about the major gold companies on his list that have held quarterly earnings calls or have other news to share.
Paradigm Capital Inc. stated in a research report that Knight Therapeutics Inc. posted significantly better than expected operating and financial results in Q2/21 that greatly exceeded analysts' estimates. Meanwhile, insiders continue to add to their positions, and the company has filed a new NCIB allowing it to purchase up to 10% of the float during the next 12 months.
Key points regarding Pan Orient Energy's second quarter performance and activities are made in a Research Capital Corp. report.
Dawson James Securities Inc. stated in a research update that Fortress Biotech Inc.'s dermatology business shows good growth potential and helped drive a positive revenue surprise in Q2/21. Dawson James has a "Buy" rating on the stock but noted that the real opportunity for the company lies with its vast pipeline and partnerships, which offer real upside potential.
Joining us is Shawn Khunkhun, CEO of StrikePoint Gold. We discuss the value proposition of the Willoughby gold project and Porter silver project, both located in British Columbia's prolific Golden Triangle. This is the most comprehensive interview to date on StrikePoint Gold, which is currently undertaking an exploration program on some very compelling projects. Find out why Eric Sprott, Crescat Capital, and Sprott Global are shareholders in StrikePoint Gold.
Technical analyst Clive Maund charts silver and explains why he believes the metal is in the “perfect” buy spot.
Shares of home improvement retailer Lowe's Companies Inc. traded higher after the company reported Q2/21 financial results and raised its FY/21 sales outlook.
Promising early results and a new line of equity support Avisa Diagnostic’s drive for IDE approval of its rapid-response breath test for pneumonia, TB, CF, and other lung ailments.
Scotiabank stated in a research report that its outlook for MAG Silver Corp. remains positive as the firm is expected to commission a new processing plant at its Juanicipio JV project in Q4/21.
The findings from the 2020 drill program at MAG Silver's joint venture project are reviewed in a PI Financial report.
Clarus Securities Inc. stated in a research report that Emerita Resources Corp.'s initial drill results from La Infanta confirm historic high grades and represent a resource with significant growth potential.
Gross sales of Stem Holdings dba Driven by Stem during the quarter were 104% higher than they were a year ago.
Troilus Gold's "Southwest zone will see a significant increase in contribution to the new resource estimate expected later in Q3/21," noted a Laurentian Bank Securities report.
Sector expert Michael Ballanger explores the reasons behind the recent "flash crash" in gold and sees opportunity given the recent market fluctuations.
Riley Gold has two cornerstone Nevada assets: the Tokop Gold Project in the Walker Lane Trend and the Pipeline West/Clipper Project in the Battle Mountain Eureka Trend—and the first results from Tokop's maiden drill program show high grades.
A Research Capital Corp. report noted "there remains upside as [Emerita Resources] continues drilling on the IBW project and the Aznalcollar dispute approaches a conclusion."
H.C. Wainwright & Co. reiterated its "Buy" recommendation for MAG Silver Corp. based upon the success of the company's FY/20 drill program that used infill and expansion drilling to greatly define surface and underground mineralization.
In a recent broadcast, Geologic and Technical Director, Dr. Quinton Hennigh discussed E2Gold Inc. and provided an update on eight other companies, all in Crescat Capital's mining exploration portfolio.
Travere Therapeutics shares traded 14% higher after the company reported positive interim results from its ongoing Phase 3 PROTECT study of sparsentan in treating IgA nephropathy, a chronic kidney disease that can lead to end-stage renal disease.
Jericho Energy Ventures focuses on advancing the low-carbon energy transition with investments in hydrogen technologies, energy storage, carbon capture and new energy systems.
Pretium Resources Inc. shares traded 17% higher after the firm reported Q2/21 financial results and advised that its cash reserves are now larger than its outstanding debt and that it remains on pace to achieve its previously issued FY/21 guidance.
McAlinden Research Partners discusses how a rise in US demand and pressures on top copper producers may spell a rebound for the red metal.
Between 1978 and 1995 estimates suggest as much as 30 million ounces of gold left the Tapajós region of Brazil in the pockets and rucksacks belonging to artisanal miners known as garimpeiros. Today, junior gold exploration company, Cabral Gold, is doing all it can to find the source of much of that gold. If successful, Cabral just might become the most successful gold junior operating in northern Brazil.
NevGold's plan to complete a resource estimate update in Q1/22 for Limousine Butte is outlined in a Caesars Report report.
An Echelon Capital Markets report noted that Osino Resources' latest drill results highlight the project's "substantial exploration potential."
The Critical Investor looks into Hawkmoon Resources' gold projects in Quebec.
Peter Epstein of Epstein Research delves into the company's exploration plans at its many Canadian gold projects.
Shares of Clover Health Investments Corp. traded higher after the company reported Q2/21 financial results that included a 140% increase in YoY revenue.
A BTIG report noted that CTI Biopharma's Pacritinib "has the potential to be a lead therapeutic in the myelofibrosis space and in additional indications that could provide material value to CTI and CTI's shares over time."
Behind that forecast, in part, are positive cannabis legislative developments and increasing consumer cannabis use, which are covered in a ROTH Capital Partners report.
Azarga Uranium Corp. has filed a robust PEA for its Gas Hills In-situ Recovery Uranium Project that estimates a total of 6.5 million pounds of U3O8 production over 7 years.
With the advent of international travel bottlenecks and a huge leap in online purchases, reliable online identity and verification is essential to derisk transactions for both consumers and merchants alike. David Lucatch, CEO of Liquid Avatar Technologies, believes his team has the right technology to derisk those "triangular" online transactions, writes Knox Henderson.
The Liquid Avatar Credential Ecosystem, or LAVCE, is designed to carry a secure, digital record of a person’s verifiable COVID-19 testing credentials, and future healthcare applications of the technology are expected.
SandRidge Energy shares rose to a new 52-week high after the company reported Q2/21 financial results and raised FY/21 production guidance after reactivating 49 producing wells.
Algernon Pharmaceuticals reported its acquisition of the exclusive rights from Dartmouth College for a method of use patent for use in treatment of neuroendocrine cancers expressing functional NMDA receptors.
Fulcrum Therapeutics shares rose 125% and set a new 52-week high after the company reported Q2/21 financial results and released positive interim results from its Phase 1 sickle cell disease trial.
Roger Moss, the CEO of Labrador Gold, sits down with Maurice Jackson of Proven and Probable to discuss his company's exploration in Newfoundland.
Family Footsteps Lead to High-Grade Gold Hunt (08/10/2021)
James Kwantes of Resource Opportunities profiles Visionary Gold and its Wyoming gold project.
A Clarus Securities report noted Emerita Resources' "IBW project alone offers significant value proposition and mergers and acquisitions appeal," and "a big prize for Emerita will be the awarding of the Aznalcollar [project] public tender."
Gatling Exploration reported it intersected 17.0m of 7.7 g/t gold and extended the Bear Deposit at its Larder Gold Project 150m up plunge confirming continuity with high-grade, near-surface mineralization.
Aurania Resources' Fruta del Norte is touted in Ecuador as a "mining operation that fits the framework envisioned by the government."
Shares of Cortexyme Inc. traded 47% higher to a new 52-week high after the company reported Q2/21 financial results and provided an update regarding its ongoing Alzheimer's and periodontal disease clinical trials.
Proven Producer Poised for the Expected Uranium Boom (08/09/2021)
Bill Powers of Mining Stock Education talks with Lotus Resources Managing Director Keith Bowes about the company's plans to advance its past-producing uranium project in Malawi.
Sector expert Michael Ballanger describes his strategy for investing in gold and silver markets in August, which has historically been, in his experience, the "singular best month of the year to acquire gold and the miners."
This acquisition "further bolsters Argentina Lithium and Energy's presence in this highly prospective salar."
Shares of Westport Fuel Systems Inc. traded 28% higher after the company announced Q2/21 financial results that highlighted a 135% YOY increase in revenues, which was attributed to substantial recovery in its independent aftermarket and light-duty OEM businesses.
Shares of STAAR Surgical Co. traded 20% higher after the company reported Q2/21 financial results highlighting a 93% YoY increase in net sales of its Implantable Collamer® Lenses.
Royal Helium Ltd. reported it has received the necessary drilling and production permits for its Climax-4 helium well in southwestern Saskatchewan and has scheduled a spud date of August 7, 2021.
In a recent Crescat Capital broadcast, Geologic and Technical Director, Dr. Quinton Hennigh introduced a new exploration company, Snowline Gold, and provided an update on seven other exploration companies, all in Crescat Capital's mining exploration portfolio.
A report by CIBC contains its full-year 2021 estimates for top pick, Endeavour Mining.
Kazatomprom's quarterly outperformance and numbers were analyzed in a BMO Capital Markets report.
Is 2021 the Breakout Year for This Yukon Explorer? (08/05/2021)
Golden Sky Minerals is mobilizing for a summer of drilling in the Yukon, while acquiring additional projects.
Adrian Day: Two Silver Company 'Best Buys' (08/05/2021)
In Adrian Day's Global Analyst, Adrian Day reviews recent developments and earnings reports at several companies, including some with high yields.
ProStar Holdings advised that its common shares have been deemed to be DTC Eligible by The Depository Trust Co. of New York.
Peter Epstein of Epstein Research speaks with Kincora Copper CEO Sam Spring about his company's exploration plans.
An H.C. Wainwright & Co. report notes that Agios Pharmaceuticals "is rapidly rebooting and has made critical progress on various fronts."
Biopharma Makes 'Solid Clinical Progress' in Q2/21 (08/04/2021)
The highlights of Oryzon Genomics' Q2/21 clinical advancements were recapped in a Roth Capital Partners report.
Maurice Jackson of Proven and Probable talks with David Cole, CEO of EMX Royalty, about the company's latest royalty portfolio purchase agreement.
Kalo Gold Holdings Corp. reported it has enlisted gold mining executive Paul Harbidge to join the company as a technical advisor and advisory committee member.
Peter Epstein of Epstein Research takes a deep dive into Sassy Resources, which he believes has two company-making project portfolios.
Novavax Inc. shares traded nearly 19% higher after the company reported the finalization of an advance purchase agreement with the European Commission to provide up to 200 million doses of its COVID-19 Vaccine.
A Haywood report noted that this new use for Exro Technologies' coil driver has "important indications to cost reduction" on both the vehicle and infrastructure sides.
A Haywood report explains the positive drill results from K92 Mining's Kora.
Rio Tinto's H1/21 cash flow, various EBITDA numbers, interim dividend and recent funding are covered in a BMO Capital Markets report.
Shares of Translate Bio Inc. soared to a new 52-week high after the company reported it agreed to be acquired by its collaborative partner Sanofi SA for $38 per share in cash in a deal valued at $3.2 billion.
Gold Prepares to Rally (08/03/2021)
Peter Krauth of Gold Resource Investor looks at macroeconomic factors and explains why he believes gold and gold stocks are good buys right now.
Independent financial analyst Matt Badiali discusses Bion Environmental Technologies' game-changing technology and explains why he believes the company is an "overnight success about to happen."
McAlinden Research Partners explores the acceleration of gene-editing technology and notes the market is poised to expand as the World Health Organization (WHO) creates new standards for companies to follow.
Explorer Hot on the Trail of Zinc in Spain (08/02/2021)
As Emerita Resources moves ahead with exploring one high-grade project, a case moving through the Spanish courts may lead it to being awarded another.
Silver Miner Advances Flagship Asset in Idaho (08/02/2021)
Maurice Jackson of Proven and Probable discusses the latest news from Lakewood Exploration with the company's president.
Shares of Annovis Bio Inc. traded 20% higher after the company reported positive interim data from its Phase 2 clinical studies of ANVS401 (Posiphen) for treatment of Alzheimer's and Parkinson's diseases.
|"For DV, we see significant growth potential around the Kitsol vein."|
|"JEV appears to be technically at a very favorable entry point."|
|"Drilling at DFN's Wicheeda yields more intercepts exceeding 3% TREOs."|
|"This is a good point to add to positions or make new purchases of RHQ."|
|"LIO's hole TUDDH608 in the 500 zone returned 23.7m of 17.89 g/t gold."|